3439 studies found for:    vaccine clinical trials
Show Display Options
Rank Status Study
1 Completed Preventative Misconception Intervention
Conditions: HIV;   HIV Infections
Interventions: Behavioral: 1-sided messages;   Behavioral: 2-sided messages
2 Completed Anthrax Vaccine Clinical Trials
Condition: Anthrax
Interventions: Drug: Anthrax Vaccine;   Procedure: Blood Chemistry;   Procedure: Hematology;   Procedure: Urinalysis
3 Completed
Has Results
HIV Testing & Womens Attitudes on HIV Vaccine Trials
Condition: HIV
Intervention: Behavioral: Message Sidedness
4 Completed Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Condition: HIV Infections
Interventions: Biological: Sub C gp140 Vaccine;   Biological: MF59C.1 Adjuvant
5 Completed CDC Anthrax Vaccine Clinical Trial
Condition: Healthy
Intervention: Biological: BioThrax or Anthrax Vaccine Adsorbed
6 Completed Hepatitis B Vaccine Clinical Trial
Conditions: Hepatitis B;   Hepatitis, Viral, Human;   Liver Diseases
Intervention: Biological: hepatitis B vaccines
7 Completed Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S)
Condition: Influenza, Human
Interventions: Biological: Trivalent Seasonal Influenza Vaccine;   Biological: Placebo Comparator
8 Completed Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1
Condition: Influenza A Subtype H5N1 Infection
Interventions: Biological: IVACFLU-A/H5N1, 7.5 mcg;   Biological: IVACFLU-A/H5N1, 15 mcg;   Biological: Placebo Comparator
9 Recruiting Screening Volunteers for Clinical Trials
Condition: Human Health
10 Active, not recruiting Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda
Condition: Hemorrhagic Fever, Ebola
Interventions: Biological: cAd3-EBOZ;   Biological: cAd3-EBO;   Biological: MVA-EbolaZ
11 Recruiting A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines
Condition: Immunologic Tests
Intervention: Other: Serum samples
12 Unknown  Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
13 Completed A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.
Condition: Ebola Virus Disease
Interventions: Biological: Low dose Ebola Zaire vaccine (Ad5-EBOV);   Biological: High dose Ebola Zaire vaccine (Ad5-EBOV);   Biological: placebo (one dose);   Biological: placebo (two doses)
14 Completed Autologous Vaccine for Follicular Lymphoma
Condition: Lymphoma, Follicular
Intervention: Biological: Autologous FL vaccine
15 Completed A Booster Dose of Ad5-EBOV in Healthy Adults After Primary Immunization
Condition: Ebola Virus Disease
Interventions: Biological: 4×10^10vp/1ml Ebola Zaire vaccine (Ad5-EBOV);   Biological: 1.6×10^11vp/2ml Ebola Zaire vaccine (Ad5-EBOV);   Biological: placebo
16 Recruiting Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Condition: Healthy Volunteers
17 Active, not recruiting Field Trial of Maternal Influenza Immunization in Asia
Condition: Influenza Human
Interventions: Biological: influenza vaccine;   Biological: saline placebo
18 Completed
Has Results
Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.
Conditions: Prospective;   Single-blind;   Clinical;   Trial;   Intervention
Intervention: Biological: BCG-vaccine (SSI)
19 Completed Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh
Conditions: Rotavirus Diarrhea;   Vaccine Virus Shedding;   Tropical Enteropathy
Interventions: Biological: IPV;   Biological: Rotarix
20 Completed
Has Results
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Conditions: Vaccines;   Meningococcal Vaccines
Interventions: Biological: rLP2086 and Gardasil;   Biological: rLP2086;   Biological: Gardasil

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years